uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntingtons Disease
| KDHAX Fund | USD 54.36 0.24 0.44% |
Slightly above 61% of Deutsche Croci's investor base is looking to short. The analysis of overall sentiment of trading Deutsche Croci Equity mutual fund suggests that many investors are alarmed at this time. Deutsche Croci's investing sentiment can be driven by a variety of factors including economic data, Deutsche Croci's earnings reports, geopolitical events, and overall market trends.
Deutsche |
U.S. Food and Drug Administration agrees that data from ongoing Phase III studies compared to a natural history external control may serve as the primary basis for a Biologics License Application for Accelerated Approval FDA agrees that the composite Unified Huntingtons Disease Rating Scale may serve as an intermediate clinical endpoint for Accelerated Approval Conference call today at 830 a.m. ET LEXINGTON, Mass. and AMSTERDAM, Dec. 10, 2024
Read at finance.yahoo.com
 |
Deutsche Croci Fundamental Analysis
We analyze Deutsche Croci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Croci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Croci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Deutsche Croci is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Deutsche Croci Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Croci mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Croci could also be used in its relative valuation, which is a method of valuing Deutsche Croci by comparing valuation metrics with similar companies.
Peers
Deutsche Croci Related Equities
| KTCSX | Deutsche Science | 0.98 | ||||
| KTCCX | Deutsche Science | 0.93 | ||||
| KTRAX | Deutsche Global | 0.23 | ||||
| KTRCX | Deutsche Global | 0.23 | ||||
| SRMAX | Deutsche Short | 0.10 | ||||
| SRMCX | Deutsche Short | 0.10 | ||||
| SRMSX | Deutsche Short | 0.10 | ||||
| GCGGX | Deutsche Gnma | 0.09 | ||||
| KTCIX | Deutsche Science | 1.30 | ||||
| KTCAX | Deutsche Science | 1.31 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Croci financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Croci security.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |